Considering all control samples, including sera from patients with colon cancer, benign breast disease, and healthy controls, yielded a specificity of 93% (139 of 149) with combined DKK3 and ITIH5 methylation. The gene discussed is DKK3; the disease is malignant colon neoplasm.